Taarifa zaidi ― Kiswahili

Urticaria mara nyingi hujidhihirisha na chembechembe zilizoinuliwa zenye kuwashwa. Wakati mwingine hufuatana na uvimbe wa tishu za msingi. Matibabu kimsingi inahusisha kuzuia vichochezi, ikiwa inajulikana. Dawa ya kwanza inajumuisha antihistamines mpya zaidi, ambayo inaweza kurekebishwa kwa viwango vya juu ikiwa inahitajika. Dawa zingine kama vile antihistamines za zamani, vizuizi vya H2, wapinzani wa leukotriene, antihistamini zenye nguvu zaidi, na kozi fupi za kotikosteroidi zinaweza kuongezwa kama usaidizi wa ziada. Katika hali ambapo urtikaria inaendelea licha ya hatua hizi, wagonjwa wanaweza kutumwa kwa wataalam kwa matibabu ya ziada kama vile omalizumab au cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Ukaguzi huu unaonyesha miongozo ya hivi punde ya kutibu urticaria na hutoa ufahamu mpya wa sababu zake.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids